www.biomedcentral.com

Table 2
Percentage of physicians who believe that available treatments at the time did not adequately treat common specific symptoms of FM*
	PCP (n=639)^a, %	Rheumatologist (n=192)^b, %	Neurologist (n=158)^c, %	Psychiatrist (n=129)^d, %	Pain specialist (n=176)^e, %
Fatigue	51	54	49	50	51
Chronic widespread pain	50	60^a	51	56	57
Difficulty concentrating	44	47	44	40	47
Numbness/tingling	40	38	35	43	40
Feelings of depression	37	38	40	33	42
Stiffness	35	33	37	37	39
Problems sleeping	31	28	34	23	36^d
Feelings of anxiety	31	34	27	25	29
Headaches	28	30	31	22	25

*At the time the survey was conducted no medications for FM were licensed in any of the countries surveyed.

^a, ^b, ^c, ^d, and ^e indicate statistically significant difference (P<0.05) among the subgroups (i.e., physician specialties) being analyzed.

Perrot et al. BMC Health Services Research 2012 12:356 doi:10.1186/1472-6963-12-356

Table 2